Trade Summary

3 days ago, Cohlhepp Ryan, serving as Pres, COO at Bicara Therapeutics Inc. (BCAX), sold 17,392 shares at $18.16 per share, for a total transaction value of $315,893.00. Following this transaction, Cohlhepp Ryan now holds 205,141 shares of BCAX.

This sale represents a 8.00% decrease in Cohlhepp Ryan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.